Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $2.4 billion.

  • Dexcom's Retained Earnings rose 5234.73% to $2.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 billion, marking a year-over-year increase of 5234.73%. This contributed to the annual value of $2.4 billion for FY2025, which is 5234.73% up from last year.
  • As of Q4 2025, Dexcom's Retained Earnings stood at $2.4 billion, which was up 5234.73% from $2.2 billion recorded in Q3 2025.
  • Dexcom's Retained Earnings' 5-year high stood at $2.4 billion during Q4 2025, with a 5-year trough of -$161.8 million in Q1 2021.
  • Its 5-year average for Retained Earnings is $895.5 million, with a median of $704.8 million in 2023.
  • In the last 5 years, Dexcom's Retained Earnings surged by 148607.14% in 2022 and then soared by 4358.27% in 2025.
  • Dexcom's Retained Earnings (Quarter) stood at $138.7 million in 2021, then soared by 246.0% to $479.9 million in 2022, then soared by 112.84% to $1.0 billion in 2023, then skyrocketed by 56.41% to $1.6 billion in 2024, then surged by 52.35% to $2.4 billion in 2025.
  • Its last three reported values are $2.4 billion in Q4 2025, $2.2 billion for Q3 2025, and $1.9 billion during Q2 2025.